Showing results (71-80 of 130) with videos related to

Sort By:
Pageof 13
Gynecologic Oncology|February 20, 2026
Para-aortic lymphadenectomy after negative PET-CT in locally advanced cervical cancer: a continuous monocentric series of 320 casesMathilde Daix-Moreux, Houssein El Hajj, Stéphanie Schérier, et al.
Cancers|March 21, 2020
Changes in DNA Damage Response Markers with Treatment in Advanced Ovarian CancerPaul Kubelac, Catherine Genestie, Aurelie Auguste, et al.
Genes, Chromosomes & Cancer|September 14, 2023
DICER1-mutated rhabdomyosarcoma of the ovary with teratoid featuresVincent Lethongsavarn, Pierre Vieille, Jeanos Kikweta Makhama, et al.
International Journal of Molecular Sciences|July 29, 2023
Combined Tumor-Based BRCA1/2 and TP53 Mutation Testing in Ovarian CancerEdith Borcoman, Elizabeth Santana Dos Santos, Catherine Genestie, et al.
British Journal of Cancer|December 18, 2019
Clinical utility of SMARCA4 testing by immunohistochemistry in rare ovarian tumoursCatherine Genestie, Félix Blanc-Durand, Aurélie Auguste, et al.
Gynecologic Oncology|January 19, 2017
Outcome of early stage cervical cancer patients treated according to a radiosurgical approach: Clinical results and prognostic factorsAlexandre Escande, Sebastien Gouy, Renaud Mazeron, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 7, 2020
Ovarian and peritoneal psammocarcinoma: Results of a multicenter study on 25 patientsJean-Baptiste Delhorme, Jordan Ohayon, Sébastien Gouy, et al.
Human Pathology|April 30, 2024
Uterine adenosarcoma: Clinical significance of histological classification and SNP array analysisCarine Ngo, Sophie Cotteret, Imène Deneche, et al.
The Oncologist|February 9, 2017
Optimizing Local Control in High-Grade Uterine Sarcoma: Adjuvant Vaginal Vault Brachytherapy as Part of a Multimodal TreatmentPierre Annede, Sébastien Gouy, Renaud Mazeron, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|April 21, 2023
Clinical transfer of AGuIX®-based radiation treatments for locally advanced cervical cancer: MR quantification and in vitro insights in the NANOCOL clinical trial frameworkPauline Maury, Michele Mondini, Cyrus Chargari, et al.
Pageof 13